Table 3.
Modificationa | Directionb | Sequence (5′- 3′)c |
---|---|---|
UL47mRFP | Forward | AGAAGATGCGAAGGAGGCGATCTTCAAAAAAACGGACCGGATGGCCTCCTCCGAGGACG |
Reverse | TCACCACGATCTGCACGCCGCTCCGTGCGCTTTTTTTTTACAAGGCGCCGGTGGAGTG | |
ΔgC | Forward | ATATACGCTCTCGGAGACGCGGCTCGCACGCCAGCTGAAATATTTTCCCCTAGTTTGCGGTGACATTGATTAGGGATAACAGGGTAATCGATTT |
Reverse | TACAAGAGCTCGGGGCATATAATGAGCCAGATCAATGTCACCGCAAACTAGGGGAAAATATTTCAGCTGGGCCAGTGTTACAACCAATTAACC | |
ΔgC-R (3 × Flag301BgC) | Forward | GGCTCGCACGCCAGCTGAAATATTTTCCCCCCCATGCACGCGTCACG |
Reverse | AATGAGCCAGATCAATGTCACCGCAAACTAGACGGACGAAAGTAATATGTATTTTTTCCCG | |
MDV gC | Forward | ATATACGCTCTCGGAGACGCGGCTCGCACGTATCTTCCCTCATGCTCACG |
Reverse | TACAAGAGCTCGGGGCATATAATGAGCCAGCATAACAATGAGATTATAAT |
aModification to the 301B/1 genome using two-step Red-mediated recombination.
bDirectionality of the primer.
cUnderlined sequence indicates start and stop codons for 301B/1 UL44 gene. Italics indicate the template-binding region of the primers for PCR amplification with pEP-mRFP-in, pEP-KanS2, pEP-301BgC-in, or pEP-MDVgC-in. Bold indicates unique upstream integration sequences. Bold italic indicates unique downstream integration sequences.